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AbstrAct
Introduction Core outcome sets are standardised lists 
of outcomes, which should be measured and reported in 
all clinical studies of a specific condition. This study aims 
to develop core outcome sets for economic evaluations 
in asthma studies. Economic outcomes include items 
such as costs, resource use or quality-adjusted life years. 
The starting point in developing core outcome sets will 
be conducting a systematic literature review to establish 
a preliminary list of reporting items to be considered for 
inclusion in the core outcome set.
Methods and analysis We will conduct literature 
searches of peer-reviewed studies published from January 
1990 to January 2017. These will include any comparative 
or observational studies (including economic models) and 
systematic reviews reporting economic outcomes. All 
identified economic outcomes will be tabulated together 
with the major study characteristics, such as population, 
study design, the nature and intensity of the intervention, 
mode of data collection and instrument(s) used to derive 
an outcome. We will undertake a ‘realist synthesis 
review’ to analyse the identified economic outcomes. 
The outcomes will be summarised in the context of 
evaluation perspectives, types of economic evaluation 
and methodological approaches. Parallel to undertaking 
a systematic review, we will conduct semistructured 
interviews with stakeholders (including people with 
personal experience of asthma, health professionals, 
researchers and decision makers) in order to explore 
additional outcomes which have not been considered, 
or used, in published studies. The list of outcomes 
generated from the systematic review and interviews 
with stakeholders will form the basis of a Delphi survey to 
refine the identified outcomes into a core outcome set.
Ethics and dissemination The review will not involve 
access to individual-level data. Findings from our 
systematic review will be communicated to a broad range 
of stakeholders including clinical guideline developers, 
research funders, trial registries, ethics committees and 
other regulators.
IntroductIon
Core outcome measures are standardised sets 
of outcomes, which represent the minimum 
set of parameters that should be measured 
and reported in all clinical studies of a specific 
condition.1 The purpose of developing 
core outcome sets is to enable the results 
of these studies to be compared, contrasted 
and combined as appropriate. Including 
core outcome sets in future studies will help 
to reduce heterogeneity between reported 
outcomes, facilitate evidence synthesis and 
minimise the risk of outcome reporting bias. 
Core outcomes should be relevant to health 
service users, people making decisions about 
healthcare, research funders, clinical guide-
line developers and other regulators.
In 2010, the Core Outcome Measures 
in Effectiveness Trials (COMET) Initiative 
was launched by the MRC North West Hub 
for Trials Methodology (NWHTMR).1 The 
COMET Initiative brings together academics, 
clinical researchers, research funders, health 
service users, policy-makers and trial regu-
lators interested in developing and using 
standardised sets of outcome measures. 
Currently, there is no such set for asthma in 
the UK and a range of reviews have identified 
a large variety of outcomes used to evaluate 
the clinical effectiveness and cost-effective-
ness of healthcare interventions for people 
with asthma.2–6
While there has been a more general move 
towards the standardisation of measures for 
economic evaluation,7–9 within the asthma 
field, the focus has tended to be in the 
context of effectiveness (rather than costs) 
as the purpose of many new treatment 
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Protocol
strengths and limitations of this study
 ► This systematic review represents a key step in 
standardising economic outcomes in asthma trials.
 ► We will produce a list of economic outcomes for use 
in future studies.
 ► We will involve stakeholders in review of findings.
 ► Quality of studies included in the systematic review 
will be not assessed given the scope of this study.
 ► Economic outcomes identified in this review (eg, 
resource use) may be not comparable to other 
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strategies is better control and avoidance of unsched-
uled healthcare use resulting from poor control. We, 
therefore, wanted to turn attention in this area specifi-
cally to economic outcomes. Aside from resource use and 
cost measures (eg, use of primary care services, hospital 
admissions, emergency department and outpatient visits, 
tests, investigations, medication and absence from work 
and school), another type of outcome that could be 
considered ‘economic’ is preference-based measures of 
health-related quality of life, such as quality-adjusted life 
years (QALYs), which are usually measured specifically to 
inform cost-effectiveness decisions at the health system 
level.
The starting point in developing core outcome sets is to 
conduct a systematic review to determine what outcomes 
are already in use and to establish a preliminary list of 
reporting items to be considered for inclusion in the core 
outcome set.10 11 We therefore present here a protocol 
for a systematic review of studies of asthma that report 
economic outcomes.
MEthods And AnAlysIs
The systematic review will be conducted using meth-
odology described in the Cochrane Handbook for 
Systematic Reviews of Interventions,12 and reported 
in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guide-
lines.13
Aims and objectives
The aim of this systematic review is to identify, evaluate 
and explain economic outcomes reported in studies of 
healthcare interventions for people with asthma.
The objectives of this systematic review are as follow:
 ► To identify, obtain and review relevant studies.
 ► To identify economic outcomes used in asthma stud-
ies.
 ► To develop lists of economic outcome measures used 
for adults, children and adolescents.
Definitions
For the purpose of this review, we will use the following 
definitions:
Economic outcomes are economic results or consequences 
of an intervention. These can be associated with resources 
(eg, number of prescriptions or days in hospital), costs, 
preference-based measurements of health-related quality 
of life, such as QALYs, combined metrics of costs and 
outcomes (eg, incremental cost-effectiveness ratio, net 
benefit or probability of intervention being cost-effec-
tive) or compliance (poor compliance is associated with a 
waste of resources).
Economic outcome measures are tools (both validated 
and non-validated) through which economic outcomes 
are assessed, for example, resource use questionnaires, 
outcome measures and proformas.
Inclusion criteria
Types of studies
Any controlled and uncontrolled experimental and 
observational studies and reviews of economic outcomes 
published in English language.
Types of interventions
1. Interventions designed to improve diagnosis, 
investigation, treatment, monitoring or management 
of asthma.
2. Interventions to improve services and their delivery 
for people with asthma.
3. Public heath interventions for asthma prevention.
Participants
Adults, children and adolescents with confirmed asthma 
diagnosis will be the participants. We will include studies 
with children aged ≥5 years due to the challenge of 
objective confirmation of asthma diagnosis in children 
<5 years.14–16 We will also exclude studies including patients 
with late asthma diagnosis (>50 years), as these are more 
likely to have a COPD–asthma overlap syndrome.17
Settings
We will place no restrictions regarding setting of care.
Types of economic evaluations
We will place no restrictions on types of health economics 
analyses.
literature search
A literature search will be conducted in two stages. 
The first step will be conducted using the following 
sources: COMET database for core outcomes in clin-
ical trials, Cochrane Library, HTA library, NHS EED, 
DARE, PubMed, EMBASE, PsycINFO, Web of Science, 
EconLit and CINAHL. In the second step, we will use a 
‘snowballing approach’, whereby reference lists and bibli-
ographies of review articles will be searched for original 
studies which were not picked up by database searches. 
Database searches will include studies published from 
January 1990 to January 2017 due to the small number of 
economic evaluations published before 1990. Titles and 
abstracts of articles will be searched using terms related to 
asthma, economic(s) and outcomes. Examples of search 
strategies are included in online supplementary appendix 
1. We will not search grey literature as this may lead to the 
double-counting of studies (eg, in conference papers and 
journal articles).
Selecting studies
To minimise the possibility of selection bias, two reviewers 
will be involved in the selection process. Initial screening 
will include titles and abstracts. The title/abstract 
screening checklist is shown in online supplementary 
appendix 2. In the second step, each reviewer will inde-
pendently read each of the studies that can potentially 
be included in the review. Any discrepancies regarding 
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will be resolved by open discussion to reach a consensus. 
A PRISMA diagram will be drawn to describe the selec-
tion process.18 Given the scope of this review, we will not 
assess the quality of the included studies. However, we will 
exclude poorly reported studies which do not provide 
sufficient information about economic outcomes for our 
analyses.
Data extraction
All identified economic outcomes will be tabulated 
together with the major study characteristics, such as 
population, study design, mode of data collection, 
the nature and intensity of the intervention and other 
outcome measures. The design of the table will be devel-
oped in due course. An example of an extraction table is 
shown in online supplementary appendix 3.
data synthesis
Data will be synthesised according to the guidelines 
for synthesising qualitative research for health tech-
nology assessments and systematic reviews.19 Due to 
the scope of the review, neither a qualitative or quanti-
tative data synthesis will produce meaningful results so, 
for the purpose of this study, we will undertake a realist 
synthesis approach.20 21 This method is increasingly used 
in evidence-based research since it applies to the real 
world of policy formation. Realist synthesis goes beyond 
creating a list of economic outcomes used in asthma 
studies. It accounts for context, questions outcome integ-
rity and compares expectations (what was intended to be 
measured) with practice (what was actually measured). 
We will be answering the following key questions: What 
type of outcome? In what studies? How measured? Does 
it answer the economic research question? Is it useful 
for decision makers? The process of realist synthesis 
is described in online supplementary appendix 4. We 
will summarise economic outcomes included in asthma 
studies in the context of population age (eg, children 
5–11 years, adults and adolescents 12+ years); evaluation 
perspectives (eg, societal, healthcare provider, personal 
social services and so on); types of economic evaluation 
(eg, cost-effectiveness, cost-utility, cost-consequences and 
cost-benefit analysis) and methodological approaches 
(eg, retrospective or prospective and data sources).
EthIcs And dIssEMInAtIon
We did not seek ethical approval for conducting the 
systematic review as it will not involve access to individ-
ual-level data. Formal ethics approval will be sought to 
conduct interviews and Delphi studies with stakeholders.
Findings from our systematic review will be communi-
cated to a broad range of stakeholders. We will work in 
close conjunction with the Asthma UK Centre for Applied 
Research (AUKCAR; http://www. aukcar. ac. uk/), which 
brings together the leading asthma researchers from 13 
universities across the UK, Asthma UK, people affected 
by asthma, NHS partners and other organisations. We will 
disseminate our findings at international workshops and 
conferences, including COMET meetings.
The next step, of developing an economic core outcome 
set for studies focusing on people with asthma, will involve 
Delphi methodology to determine which economic 
outcomes should be included in effectiveness studies.10 11 
Findings from this systematic review will inform protocol 
development for the Delphi consensus process. A national 
expert panel will be convened for round-table discussions 
to a group of experts from the Asthma UK Centre for 
Applied Research. The panel will include representatives 
from the AUKCAR Patient Advisory Group, consisting 
of people with mild to severe and brittle asthma, as well 
as parents, relatives and carers of people with asthma, 
to identify important economic outcomes. Once a 
consensus on an outcome set is reached, an international 
workshop will be convened to discuss the applicability 
of the Delphi-generated core outcome set across inter-
national settings and relevant disciplines. Subsequent 
developments of the core outcome set will be validated 
internally (via a further expert panel) and externally (by 
including in national/international asthma studies). To 
ensure uptake of the core outcome set, we will engage 
with clinical guideline developers, research funders, trial 
registries, ethics committees and other regulators.
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